5
Participants
Start Date
October 31, 2024
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
Valine oral solution (50mg/ml) and isoleucine oral solution (25mg/ml)
Subjects will take valine oral solution (50mg/ml) in place of usual powdered valine supplement for 28 days. Subjects will then take isoleucine oral solution (25mg/ml) in place of their usual powdered isoleucine supplement for 28 days.
Lead Sponsor
Birmingham Women's and Children's NHS Foundation Trust
OTHER
Meta Healthcare Ltd
INDUSTRY